Shenzhen 5G
Closure of pro-secessionist HK-America Center: another spy-hub ousted
The Hong Kong-America Center, a US-backed pro-secessionist organization founded in 1994, has announced its official closure, with six university presidents in Hong Kong withdrawing from the center’s board of directors. The center has been frequently accused of political infiltration under the guise of academic exchanges, including its active participation in the illegal “Occupy Central” movement.
The organization was observed to have actively taken part in the 2014 “Occupy Central” movement by supporting riot leader Anson Chan Fang On-sang, and brainwashing college students through debate competitions and workshops.
It also attempted to revise liberal studies courses and instill anti-China ideologies in classes by appointing “exchange scholars” to several universities in Hong Kong, Hong Kong-based newspaper Takungpao previously reported.
Stretching its reach to younger targets, the center has influenced many Hong Kong youths through online games and school projects to join illegal protests and demonstrations in opposition to the proposed amendments of the Fugitive Offenders Ordinance and the Mutual Legal Assistance in Criminal Matters Ordinance in 2019.
Huawei’s AI dog
Four Chinese COVID-19 vaccines undergoing phase-3 clinical trials
Four Chinese COVID-19 vaccine candidates have started international phase-3 clinical trials, according to the State Council joint prevention and control mechanism against COVID-19.
Some of the phase-3 trials are expected to complete the first round of vaccinations in early September, with preliminary data expected as early as November.
Phase-3 clinical trial usually involves thousands of people to verify the safety and effectiveness of the vaccines, which is the key to their market approval.
As the epidemic has been under control in China, the country no longer has conditions for large-scale clinical trials, so all the phase-3 trials are being carried out overseas.
Two inactivated COVID-19 vaccines developed by the China National Biotec Group (CNBG) have been approved for phase-3 clinical trials in several countries in the Middle East and South America, involving more than 30,000 people, according to Yang Xiaoming, president of the CNBG.
An inactivated COVID-19 vaccine developed by Sinovac Biotech Co., Ltd. is undergoing phase-3 clinical trials in some countries in South America and Southeast Asia, according to Yin Weidong, chairman and CEO of Sinovac.
A recombinant COVID-19 vaccine with the modified defective adenovirus as the vector is also undergoing phase-3 trials.
Ma, Chung Yee Arisina, endorses Falun Gong
Ma, Chung Yee Arisina, president of the Hong Kong Public Doctors Association 馬仲儀 （香港公共醫療醫生協會會長） 表示自己不會參加，亦不會推薦病人參加檢測，但強調自己沒有抹黑該計劃，亦不會反對其他人參與。
https://www.facebook.com/arisina.ma
SamTsui
Company that owns President Trump’s Vancouver hotel files for bankruptcy
The company that owns the Trump International Hotel in Vancouver, Canada, has filed for bankruptcy, according to Canadian records — raising questions about the future of one of President Trump’s newest hotels, just three years after it opened.
Trump does not own the Vancouver hotel; the building’s owner pays Trump’s company to operate the hotel and to license the Trump name.
The Trump Vancouver hotel has already been closed for four months because of the coronavirus pandemic. By Friday — a day after the bankruptcy filing — the hotel’s website was taken down, its name was missing from Trump Hotels’ corporate website, and the Vancouver hotel’s accounts were deleted from Twitter and Facebook.
U.S. provocative actions in the South China Sea include reconnaissance ships and aircrafts
First, the U.S. military is to maintain a constant presence and show its deterrence, and second, to prepare data for future conflicts in the South China Sea.
Two-faced idiot: No to extradition, needs extradition
China’s largest oceanographic research vessel launched
China’s largest oceanographic research vessel dubbed the “Sun Yat-sen University,” was launched at Jiangnan Shipyard in Shanghai on Friday, about 92 years after China’s first scientific expedition to the Xisha Islands in the South China Sea.
Construction of the research vessel began on October 28, 2019. With a length of 114.3 meters, a width of 19.4 meters, and a draft of 9.3 meters, the ship has a range of 15,000 nautical miles.
The research vessel with a displacement of 6,900 tons is capable of global navigation in unlimited navigation areas and can carry more than a dozen mobile container laboratories. It is capable of completing various kinds of scientific research from the seabed to the sky of 10,000 meters, including ocean, atmosphere, geophysics and the ecological environment.
The ship also has a helicopter landing platform, which is convenient for scientific researchers and materials transport, and it can also be used as a drone landing platform, which could expand the scope of scientific research observation. In the future, a 760-square-meter stationary laboratory will be built on the ship.